Page 27 - தொழிற்சங்கம் பாதுகாப்பு அமைச்சர் ராஜ்நாத் சிங் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
DRDO s anti-COVID drug 2-DG will reduce recovery time, oxygen dependency, says Union Health Minister
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
DRDO s anti-Covid drug 2-DG will reduce oxygen dependency: Harsh Vardhan
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
COVID-19: The 2-G drug had shown promising results in its phase 2 and phase 3 clinical trials.
New Delhi:
An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched tomorrow, with Union Defence Minister Rajnath Singh distributing around 10,000 doses to some hospitals in the national capital.
The drug, called 2-deoxy-D-glucose or 2-DG, was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy s Laboratories. The Drugs Controller General of India (DCGI), the country s top drug regulator, has approved the medicine for emergency use.
The drug had shown promising results in its phase 2 and phase 3 clinical trials. The medicine was found to be safe for COVID-19 patients in phase 2 trials, conducted between May and October last year. It was found to be effective in cutting short the hospital stays of Covid patients and reducing their supplemental oxygen dependence.
Representative image | Punit Paranjpe / AFP
India on Sunday registered 3,11,170 new coronavirus cases, pushing the country’s tally of infections since the pandemic began in January 2020 to 2,46,84,077. The toll rose by 4,077 to 2,70,284.
Mumbai Mayor Kishori Pednekar said that coronavirus vaccination is likely to be suspended in the city on Monday due to Cyclone Tauktae. It will resume from Tuesday. In Gujarat, vaccinations will be on hold till Tuesday.
The Centre on Sunday issued new coronavirus-related guidelines for peri-urban, rural and tribal areas, taking note of the “gradual ingress” of the infection in these regions.
The Centre on Sunday said that more than 1.84 crore doses of coronavirus vaccines were available with states and they will receive nearly 51 lakh more over the next three days. Meanwhile, the CoWIN portal used for online registration of coronavirus vaccines has been reconfigured to reflect the extension of interval for two doses of
DRDO s anti-COVID-19 pill 2DG to be launched on May 17
Super macro of medical pills
New Delhi: Giving itself options in treatment of Covid, an anti-coronavirus drug developed by the Defence Research and Development Organisation (DRDO) will be launched on Monday.
During the soft launch, Union Defence Minister Rajnath Singh will distribute around 10,000 doses to some hospitals in the national capital.
The drug which has a tongue twister name 2-deoxy-D-glucose or 2-DG was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy s Laboratories. The Drugs Controller General of India (DCGI), the apex body, has approved the medicine for emergency use.
vimarsana © 2020. All Rights Reserved.